An Institute Devoted to Translational Biomedical Research

Home  |  Contact  |  Links  |  简体中文版
  About Us Research Graduate Education Cooperation and Exchange Translational Research System Technology Platforms Faculty and Staff Join Us  
In the news
Introduction of IHS in Immunology
From Immunology to stem cells, searching for new strategies to treat human disease
Posted on Dec 5, 2012

Introduction of IHS in International Innovation
The world leading research publication
Posted on Dec 5, 2012
Picture News  

Cell Death, Stem Cell and Heart Failure
May 23, 2014, Shanghai, China
Research Progress
Foxd3 suppresses NFAT-mediated differentiation to maintain self-renewal of embryonic stem cells.

Zhu L, Zhang S, Jin Y.

EMBO Rep. 2014 Nov 6. pii: e201438643.
Degradation of cardiac myosin light chain kinase by matrix metalloproteinase-2 contributes to myocardial contractile dysfunction during ischemia/reperfusion.

Ling Gao, Yan-Jun Zheng, Shan-Shan Gu, Ji-Liang Tan, Christian Paul, Yi-Gang Wang, Huang-Tian Yang.
J Mol Cell Cardiol. 2014 Dec;77:102-112.
Upcoming Seminars
Lab Meeting: Pluripotent Stem Cells for Cardiovascular Research Assay Development and Later Clinical Application
Guest Seminar: 多能干细胞与心血管转化医学
News and Events
Evidences for splicing noise as the main cause of alternative splicing at GYNNGY 5’ splice sites
Foxd3 Suppresses NFAT-mediated Differentiation to Maintain Self-renewal of Embryonic Stem Cells
The Institute of Health Sciences (IHS), jointly founded in 1999 by Shanghai Institutes for Biological Sciences (SIBS) of the Chinese Academy of Sciences (CAS) and Shanghai Jiao Tong University School of Medicine (SJTUSM), is devoted to translational biomedical research.
Copyright 2002-2014 The Institute of Health Sciences, SIBS, CAS / SJTUSM All Rights Reserved
225 South Chongqing Road, Shanghai, 200025 P.R. China Tel: 86-21-63847798 / 54923254 Fax: 86-21-63852579
Shanghai ICP #05033115